RGT 0.00% 31.0¢ argent biopharma limited

Ann: First CannEpil Delivered to UK Patients, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 14,150 Posts.
    lightbulb Created with Sketch. 2425
    To date, this is the only product that MXC has come up with that actually works. Why has it taken 5 years to get to this point - and why has MXC not pushed this product harder and faster.

    Highlights
    • CannEpil®, MGC Pharma’s Investigational Medicinal Product (“IMP”) has now been
    successfully imported and received by its first patients in the United Kingdom.
    • The first UK patient has received CannEpil® through the ‘I AM Billy Foundation’, supporting
    the RESCAS study.
    • Additionally, the Company has delivered CannEpil® to its first patient in the UK via the Named
    Patient Request programme.
    • This follows the announcement on 11 April 2023 that CannEpil® was now available in the
    United Kingdom via Named Patient Request, and available to be prescribed by doctors on
    The General Medical Council (“GMC”) specialist register across the UK.
    • CannEpil® is in the process of a clinical development programme for patients suffering from
    refractory (or drug-resistant) epilepsy.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.000(0.00%)
Mkt cap ! $16.82M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 1612 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 50 1
View Market Depth
Last trade - 16.12pm 31/10/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.